A Controlled, Randomized Study to Assess the Quantitative Mass Transfer of Iron From SFP-containing Hemodialysate Under Varying Conditions of Blood and Dialysate Flow Rates, Dialyzer Membrane Types and Dialysate Bicarbonate Concentrations in CKD-HD Patients.
Latest Information Update: 03 Oct 2021
Price :
$35 *
At a glance
- Drugs Ferric pyrophosphate (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- Sponsors Rockwell Medical Technologies
- 29 May 2015 New trial record